Liminal BioSciences Inc. Banner Image

Liminal BioSciences Inc.

  • Ticker LMNL
    Exchange TSX More
  • Industry Biotechnology More
  • Sector Healthcare More
Liminal BioSciences Inc. Logo Image
  • 201-500 Employees
  • Based in Laval, Quebec
Liminal Biosciences is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases related to fibrosis. The company is advancing promising research in small molecules for a range of diseases related to fibrosis including respiratory, liver and renal diseases. Through a separate business unit calledMore Prometic, the company also focuses on the use of bioseparation technologies to isolate and purify biopharmaceuticals derived from human plasma.
4.8 / 5.0 (107)

Liminal BioSciences Inc. reports have an aggregate usefulness score of 4.8 based on 107 reviews.

Liminal BioSciences Inc.

Most Recent Annual Report

Liminal BioSciences Inc.
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Liminal BioSciences Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!